angiotensin receptor blocker

angiotensin receptor blocker (ARB),

agent that binds with angiotensin receptors, thus preventing access of angiotensin II to the receptor and consequently reducing the vasoconstriction produced by this agonist; used in the treatment of hypertension.

angiotensin II receptor antagonist

Any of a family of agents (e.g., losartan and valsartan) that block the binding of angiotensin II (A-II) to their cognate cell receptors—AT1, AT2 and others. First-generation ARAs included the sartan family of agents, which only block AT1, interacting with the amino acids in the transmembrane domains to block the binding of A-II to AT1.

ARAs are an alternative to ACEI therapy in patients with CHF; unlike ACEIs, ARAs do not interfere with bradykinin and prostaglandin metabolism, interference of which has been linked to some of the adverse effects of ACEI therapy, particularly to cough and angioedema.

an·gi·o·ten·sin re·cep·tor block·er

(an'jē-ō-ten'sin rĕ-sep'tŏr blok'ĕr)

An agent (e.g., losartan) that binds with angiotensin receptors, thus preventing access of angiotensin II to the receptor and consequently reducing the vasoconstriction produced by this agonist; used in the treatment of hypertension.

References in periodicals archive ?

Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis.

ACE inhibitors and ARBs: one or the other--not both--for high-risk patients: the combination of an ACE inhibitor and an ARB reduces proteinuria, but leads to worse renal outcomes

Entresto is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other angiotensin receptor blocker (ARB).

Switzerland : New analyses show Novartis Entresto(TM) reduced cardiovascular death or hospitalization for heart failure, consistently benefitting patients with reduced ejection fraction regardless

The drug is indicated for treating high blood pressure in patients not adequately controlled on aliskiren or angiotensin receptor blocker (ARB) monotherapy and as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals.

New hypertension treatment option

The measures identified for heart failure include discharge instructions, left ventricular function assessment as measured by an echocardiogram, discharge prescription for an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker for left ventricular systolic dysfunction, and smoking cessation advice/counseling.

Heart failure

The angiotensin-converting enzyme inhibitor (ACEI) ramipril and the angiotensin receptor blocker (ARB) telmisartan are equally effective for secondary cardiovascular prevention.

Ramipril and telmisartan: equally effective for patients at high risk of vascular events?

Norvasc, a calcium channel blocker, relaxes blood vessels, while olmesartan uses an angiotensin receptor blocker to ease blood-vessel constriction.

Daiichi Sankyo Co's experimental blood pressure drug combining its Benicar pill with the active ingredient in Pfizer Inc's Norvasc lowered hypertension more effectively than either medicine alone, a study found

An angiotensin receptor blocker (ARB) discovered by Takeda, TAK-491 helps lower blood pressure by suppressing the action of vasopressor hormone Angiotensin II.

Takeda Pharmaceutical Initiates Phase II Clinical Test for Compound TAK-491 for Treatment of Hypertension

Novartis AG, Basel, Switzerland, announced the US Food and Drug Administration (FDA) has approved Diovan, the most prescribed angiotensin receptor blocker (ARB) worldwide, for a new indication to reduce cardiovascular death in patients with high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.

Novartis gets FDA approval for heart attack treatment; acquires rights to develop new dialysis treatment

The company stated that Entresto is usually administered along with other heart failure therapies in place of an ACE inhibitor or other angiotensin receptor blocker.

Novartis receives approval for Entresto

Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.

Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction/Hafif ve orta derecede sol ventrikul disfonksiyonu olan hastalarda renin-anjiyotensin-aldosteron sistem blokerleri ile kalp cerrahisi sonrasi gelisen atrial fibrilasyon arasindaki iliski